AskMuncher
4年前
$SCNNF Sativa Wellness Group Inc. Provides Annual General and Special Meeting Update
Press Release | 01/29/2021
VANCOUVER, BC / ACCESSWIRE / January 29, 2021 / Sativa Wellness Group Inc. (CSE:SWEL) ("Sativa Wellness" or the "Company") is pleased to announce the results of the Company's Annual General, and Special Meeting of the shareholders held on January 26, 2021 (the "Meeting"). There were 97,361,247 shares voted, representing 32.18% of the total shares issued and outstanding. A majority of the shareholders voted to accept the financial statements for each of the 2019 and 2020 fiscal years. The shareholders unanimously voted to set the number of directors at six. Each of Henry Lees-Buckley and Jason Dussault declined their respective nominations as a Director of the Company. The remaining management recommendations for directors, namely, Jonathan Wearing, Joseph Colliver, Angus Kerr, and Mark Blower, accepted their respective nominations as Directors of the Company. There were two nominations for directors from the floor, namely, Geremy Thomas and George Thomas. The Company held a ballot for the election of the directors, and the percentage of votes cast for each director are as follows:
Jonathan Wearing - 99.99%
Joseph Colliver - 99.91%
Angus Kerr - 99.96%
Mark Blower - 98.84%
George Thomas - 100%
Geremy Thomas - 100%
In addition, the Company is pleased to announce that RSM Canada has been appointed as auditors of the Company for the upcoming year. A majority of the shareholders voted against the resolution to approve the Company's stock option plan.
The Company is pleased to announce that pursuant to the reverse takeover of Stillcanna Inc., the fiscal year-end of the Company has changed to December 31, which is reflected in the Company's Notice of Change of Corporate Structure filing under the Company's profile on www.sedar.com. The change of the Company's year-end is expected unlock synergies amongst the vertically integrated operating subsidiaries of the Company and is intended to lead to cost savings going forward.
The Directors of the Company accept responsibility for the contents of this announcement. Further information regarding the Company, including the AGM information circular, can be found at www.sedar.com.
Further information on Geremy Howard Prance Thomas:
Geremy Thomas currently has an interest of 78,406,380 common shares in the Company, representing 25.9 % of the Company's issued share capital. Geremy owns 12,464,890 options exercisable at C$ 0.02509 per share.
Current Directorships
Previous Directorships
Carbon Managers Limited
Sativa Group Plc
Low Carbon Leasing Ltd
George Botanicals Ltd
Phytovista Laboratories Ltd
Goodbody Botanicals Ltd
Sativa Foundation
Tessellate Collective Ltd
Goodbody & Blunt Limited
Goodbody Wellness Ltd
Sativa Research and Development Ltd
Sativa Wellness Ltd
Sativa Cultivation and Extraction Ltd
Geremy is an entrepreneur with a successful track record in the telecommunication, e-learning and consumer finance industries. Geremy co-founded The Carphone Group Plc in the late 1980's before selling it to Cable & Wireless. He then went on to create and list PNC Telecom Plc. In 2001 Geremy co-founded TMTI Ltd. TMTI Ltd is a profitable technical support business which works with major brands in enhancing the customer experience. Geremy founded George Banco ltd in 2013, a consumer finance business, which was later sold to Non Standard Finance Plc. Geremy's other business interests include Carbon Managers Ltd, an environmental services consultancy company. More recently, Geremy founded the Sativa Group.
Further information on George Thomas:
George Thomas currently has an interest of 6,198,795 common shares in the Company, representing 2.0% of the Company's issued share capital. George owns 670,140 options exercisable at C$ 0.11973 per share.
Current Directorships
Previous Directorships
Tessellate Collective Ltd
George Banco Ltd
Goodbody Botanicals Ltd
Phytovista Laboratories Ltd
George Botanicals ltd
Carbon Managers Ltd
George is a successful entrepreneur who has established an eclectic mix of businesses across an array of industries, including Tech, Finance, Environmental and Wellness. George was a founding director and board member of George Banco Ltd, a consumer finance business, which was later sold to Non-Standard Finance Plc. He is the managing Director of Goodbody Botanicals Ltd, the main operating subsidiary of the Sativa Wellness Group through which he has successfully introduced a range of wellness products and services.
On behalf of the Board of Directors,
Jonathan Wearing
Chairman of the Board of Directors
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
enquiries@sativawellnessgroup.com
www.sativawellnessgroup.com
Joseph Colliver
Chief Financial Officer
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
enquiries@sativawellnessgroup.com
www.sativawellnessgroup.com
Neither the Canadian Securities Exchange nor its Market Regulator (as defined in the policies of the Canadian Securities Exchange) accept responsibility for the adequacy or accuracy of this release.
This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes" "plan is" or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur", "will be achieved" or "shortly"..
Although Sativa Wellness believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. In particular, there is no guarantee that any cost synergies will be realized, overhead costs will be reduced or that the new Directors will be approved by the Exchange. The forward-looking information and forward-looking statements contained in this news release are made as of the date of this press release, and Sativa does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.
SOURCE: Sativa Wellness Group Inc.
View source version on accesswire.com:
https://www.accesswire.com/626664/Sativa-Wellness-Group-Inc-Provides-Annual-General-and-Special-Meeting-Update
catdaddyrt
4年前
Dragonfly is out - good riddance - soon grasshopper we begin
1st week of Sept. -- revenue is on the way for the SCNNF holders at last.Still a long position to reap the real money. I have plenty of time I can even hang out in a barr and wait for my money.
Nothing Ventured Nothing Gained rules of the land
CBD will be bigger than Weed in the end may take a while but it will come.
Stillcanna's Acquisition of Sativa Group PLC of the United Kingdom Receives 99% Shareholder Approval from Sativa
[ACCESSWIRE]
ACCESSWIRE•August 19, 2020
VANCOUVER, BC / ACCESSWIRE / August 19, 2020 / Stillcanna Inc. (OTC PINK:SCNNF) (CSE:STIL) (FRANKFURT:A2PEWA) ("STIL" or the "Company"), is pleased to announce that the shareholders of Sativa Group PLC, one of the United Kingdom's (UK) first medical Cannabis Companies, have overwhelmingly voted in favour of the acquisition.
On August 27, 2020 Stillcanna is holding a special meeting of its shareholder to vote on the Sativa Group acquisition. It is anticipated that Stillcanna shares will resume trading the first week of September.
The details of the acquisition were previously announced on June 3, 2020. Stillcanna will continue to trade, or otherwise be quoted on the CSE, OTC and FSE following completion of the acquisition. Stillcanna intends to list the Stillcanna shares on the AQSE on or shortly after the effective date in order to maintain access to the AQSE for shareholders of the combined group. This is subject to Stillcanna completing the relevant admission process with the AQSE.
"I am delighted the Sativa shareholders have so fully embraced our proposed acquisition of the Sativa Group of Companies," stated Jason Dussault CEO of Stillcanna. We are fast approaching the final stages of this acquisition and the entire Stillcanna team looks forward to monetizing on the combined strengths of the new entity."
As previously announced on April 21, 2020 all required licenses and permits to commence the manufacturing of CBD at the ORIGIN extraction facility have been secured. The facility was constructed through a joint venture partnership with Dragonfly Biosciences Limited of the UK. Borganic Consulting had initiated legal action in the UK against Dragonfly Biosciences for contractual breaches under the partnership agreement.
Further to the announcement on April 21, 2020 Stillcanna Inc.'s subsidiary Borganic Consulting Inc. ("Borganic") has, with immediate effect today, terminated its Joint Venture agreement dated December 4, 2018 with Dragonfly Biosciences Limited ("Dragonfly").
The termination includes a claim for Dragonfly's share of the Joint Venture extraction facility.
Proceedings issued in the English High Court have also been served by Borganic today on Dragonfly and also on Ms Radostina Draganova-Nikolova, a director of Dragonfly and general manager of the Joint Venture company.
In the proceedings served by Borganic it seeks declarations from the English High Court that:
Dragonfly has materially and persistently breached the Joint Venture agreement which constitutes a compulsory transfer event in favour of Borganic;
The notice of termination and compulsory transfer event served by Dragonfly on August 3, 2020 is null and void; and
Borganic retains ownership in the equipment it has financed at the Joint Venture extraction facility.
Borganic also claims damages against Dragonfly for the losses it has suffered as a result of Dragonfly's alleged breaches of the Joint Venture agreement.
About Sativa Group PLC
The Sativa Group PLC joined the UK's NEX market in March 2018 as the UK's first medicinal cannabis investment vehicle.
The business evolved to focus on the development of an operational business capitalizing on its first-mover advantage. This change transitioned the Company from an investment Company to an operating Company at the forefront of both the CBD wellness and medicinal cannabis sectors in the UK.
About Stillcanna Inc.
Stillcanna Inc. (CSE: STIL) www.stillcanna.com is a Canadian early-stage life sciences Company focused on the large scale manufacturing of CBD in Europe. The Company believes its proprietary intellectual property allows it to extract CBD at a lower cost. The Company has signed an initial extraction contract in Europe to be the exclusive extractor for Dragonfly Biosciences LLC, a United Kingdom-based supplier of CBD. The Company also recently completed the of Olimax NT SP. Z .O.O, a multi-generational hemp agricultural firm that is expected to increase the Company's market share in the European CBD industry.
catdaddyrt
4年前
Yes it is very good for us Sativa Group is our vehicle to market and they have done well the last couple of years-will resume trading in August I guess that's a long time on an accquistion imo
Quarter 1 2020 Management Accounts Highlights
3 June 2020
Sativa Group Plc (AQSE: SATI), (or “Sativa” or “the Company” or “the Group”), the UK’s leading quoted CBD wellness and medicinal cannabis company, is pleased to announce its audited results from the year ended 31 December 2019, and draft unaudited Quarter 1 2020 interim management results.
Highlights:
Revenue increased by greater than five-fold from £0.26m to £1.45 million in the year to 31 December 2019, representing an increase of 190% on the annualised run rate of the revenue reported in H2 2018.
Gross profit margin improved from 42% to 52%, due to a decrease in the cost of CBD extract and production efficiencies, within market expectations.
The Group continues to expand its range of products, with the launch of the flagship Goodbody Botanicals brand, targeted at high-street pharmacies, grocers and independent pharmacies, and Goodbody Wellness, the premium health and beauty range.
The Tessellate Collective business was launched in Q2, opening up a new revenue stream as the direct selling channel.
Distribution partnership agreement signed with SHS Retail & Distribution a leader in distribution to high street grocers and pharmacies.
Sativa Cultivation & Extraction awarded a Home Office Controlled Drug licence, to fulfil its research partnership agreement with King’s College London.
Henry Lees-Buckley appointed as Chief Executive Officer in August. Henry was previously CEO of Uni-Select [TSX:UNS], a Canadian TSX quoted company.
Clive Page OBE, Professor of Pharmacology at King’s College London, appointed to Scientific Advisory Board.
PhytoVista Laboratories, increasingly recognised as a leading UK analytical laboratory for the testing of cannabinoids and terpenes, completed it’s 3,000th cumulative sample test in December, 90% of which was for external CBD and food manufacturers.
The Company completed a £1.38 million (before costs) share placement and subscription in December, the majority of which came from existing shareholders.
Full Results can be accessed from our Shareholder information Page
For further information please contact:
Henry Lees-Buckley
Chief Executive Officer
Sativa Group Plc
+44 (0) 20 7971 1255
enquiries@sativagroup.co.uk
www.sativagroup.co.uk
Joseph Colliver
Chief Financial Officer
Sativa Group Plc
+44 (0) 20 7971 1255
enquiries@sativagroup.co.uk
www.sativagroup.co.uk
M&A | Healthcare
Stillcanna to acquire UK based Sativa Group
Jun. 3, 2020 1:50 PM ET|About: Stillcanna Inc. (SCNNF)|By: Akanksha Bakshi, SA News Editor
Stillcanna (OTC:SCNNF) announces the acquisition of Sativa Group PLC, one of the United Kingdom's first medical cannabis companies.
The Offer is a share for share exchange offer at a ratio of ~0.33507 new Stillcanna shares in exchange for each share of Sativa; the exchange ratio attributes an implied value for the entire issued share capital of Sativa of ~£10.41M.
Stillcanna will continue to trade, on the CSE, OTC and FSE following completion, expected in August 2020.
Stillcanna has begun its Novel Food Application and has hired Global Regulatory Services of the UK, an award winning global consulting firm with a specialty in Novel Food applications.
Stillcanna has begun its agricultural initiatives in Europe to secure a steady availability of hemp biomass for the NEXUS extraction facility in Poland for 2020 and 2021.
Company has agreements with multiple European based hemp farmers to assure high CBD content EU compliant hemp biomass for 2020, and anticipates processing a minimum of 18,000 kilos of biomass in its Polish facility every month but could double that amount should the market demand be there.
Hot Features
プレミアム
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
MU_Redskin1
2年前
exisnet
3年前
Renee
3年前
Mle660
3年前
Natural Trader
3年前
bar1080
3年前
RHF469usa
4年前
drmaddogs2
4年前
